Business
Press Release Sep 09 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled "Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled "Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd